Skip to content
  • Newsroom
    • Eye on Employee Benefits Blog
    • ERIC in the News
    • Media Contact Info
    • Staff Bios
  • My Account
  • Contact Us
  • About ERIC
    • How ERIC Is Different From Other Trade Groups
    • ERIC’s Board of Directors
    • Employee Benefit Job Postings
    • ERIC’s Advisory Council
    • Member Directory
    • Policy Priorities
    • Celebrating 50 Years of Service
  • Health Care
    • Federal
    • State & Local
    • Biosimilars: Cost Savings & Competition
    • E-Delivery for Health & Welfare Plans
    • Solutions for Mental Health – Addressing Mental Health Disparity
  • Retirement & Compensation
    • Federal
    • State & Local
    • Employers & State Paid Leave Patchwork
  • Paid Leave & State Mandates
    • Paid Leave
    • State Health Reform Efforts
    • Biosimilars
    • State Retirement Plans
    • Telehealth
    • State Resources
  • Advocacy & Litigation
    • Protecting ERISA Preemption
    • ERIC Legal Center
    • Litigation
    • Amicus Briefs
    • Letters to Lawmakers
    • Letters to Agencies
    • Testimony
    • Surveys
    • ERIC Wins
  • Events & Meetings
    • Calendar of Events
    • Webinar Library
    • Policy Conferences
    • Sponsor an Event
  • Newsroom
    • Eye on Employee Benefits Blog
    • ERIC in the News
    • Media Contact Info
    • Staff Bios
  • My Account
  • Contact Us

Category Archives: Prescription Drugs

ERIC Submits Comments on Mississippi’s Part 2640 Proposed Rules

On behalf of The ERISA Industry Committee (ERIC), thank you for accepting input from interested stakeholders as you consider the Mississippi State Board of Medical Licensure proposed rules for Part 2640

Survey Results, Final Medicare Comments, FDA News, and More

Sorry, but you do not have permission to view this content.

Individual Mandate Repealed, Rx Costs in the Crosshairs, ER Mandate Penalties, and More

Sorry, but you do not have permission to view this content.

Nominations News, Rx Costs on the Hill, DRIVE, and America’s Health Rankings

Sorry, but you do not have permission to view this content.

State Law Claims Federally Preempted in Amgen v. Sandoz

Sorry, but you do not have permission to view this content.

ACA Taxes, Big DRIVE Health News, Rx Costs, and More!

Sorry, but you do not have permission to view this content.

MHP, Rx Costs, the State of ESI, and More!

Sorry, but you do not have permission to view this content.

HHS Nominee Hearing Coming, End-of-Year Health Care Legislation, HSA Action, and More

Sorry, but you do not have permission to view this content.

Tax reform, Opioids, San Francisco, and More!

Sorry, but you do not have permission to view this content.

Market Stabilization, HIPAA Relief, Wellness, Opioids, and More

Sorry, but you do not have permission to view this content.

Posts pagination

Newer posts 1 … 23 24 25 26 27 28 Older posts
  • Newsroom
  • My Account
  • Contact Us
  • Privacy Policy
1032 15th St. NW, Suite 390, Washington, DC 20005-1503 | Phone: (202) 789-1400 | Fax: (202) 789-1120
© 2026 The ERISA Industry Committee. All Rights Reserved.

Web Design & Development by Matrix Group International, Inc